IT8467767A1 - Preparati farmaceutici ad attività antimicrobica e procedimento per la loro preparazione. - Google Patents

Preparati farmaceutici ad attività antimicrobica e procedimento per la loro preparazione.

Info

Publication number
IT8467767A1
IT8467767A1 IT1984A67767A IT6776784A IT8467767A1 IT 8467767 A1 IT8467767 A1 IT 8467767A1 IT 1984A67767 A IT1984A67767 A IT 1984A67767A IT 6776784 A IT6776784 A IT 6776784A IT 8467767 A1 IT8467767 A1 IT 8467767A1
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical preparations
antimicrobial activity
antimicrobial
Prior art date
Application number
IT1984A67767A
Other languages
English (en)
Other versions
IT1179029B (it
IT8467767A0 (it
Original Assignee
The Liposome Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Liposome Company Inc filed Critical The Liposome Company Inc
Publication of IT8467767A0 publication Critical patent/IT8467767A0/it
Publication of IT8467767A1 publication Critical patent/IT8467767A1/it
Application granted granted Critical
Publication of IT1179029B publication Critical patent/IT1179029B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT67767/84A 1983-08-01 1984-08-01 Preparati farmaceutici ad attivita antimicrobica e procedimento per la loro preparazione IT1179029B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51891283A 1983-08-01 1983-08-01
US06/633,481 US5000958A (en) 1983-08-01 1984-07-26 Enhancement of pharmaceutical activity

Publications (3)

Publication Number Publication Date
IT8467767A0 IT8467767A0 (it) 1984-08-01
IT8467767A1 true IT8467767A1 (it) 1986-02-01
IT1179029B IT1179029B (it) 1987-09-16

Family

ID=27059635

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67767/84A IT1179029B (it) 1983-08-01 1984-08-01 Preparati farmaceutici ad attivita antimicrobica e procedimento per la loro preparazione

Country Status (11)

Country Link
US (1) US5000958A (it)
EP (1) EP0153364B1 (it)
AU (1) AU3219484A (it)
CA (1) CA1237671A (it)
DE (1) DE3483322D1 (it)
ES (1) ES542147A0 (it)
IL (1) IL72545A (it)
IT (1) IT1179029B (it)
PT (1) PT79012A (it)
SG (1) SG18592G (it)
WO (1) WO1985000515A1 (it)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU588299B2 (en) * 1985-04-08 1989-09-14 Rafa Laboratories Ltd. Artificial microcompartmentalization
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
JP2579625B2 (ja) * 1985-07-05 1997-02-05 ザ リポソ−ム カンパニ−，インコ−ポレイテツド 改良された取り込み効率を有するマルチラメラリポソ−ム
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
MX9203504A (es) * 1988-04-20 1992-07-01 Liposome Co Inc Complejo agente: lipido activo de alta proporcion.
DE68916956T2 (de) * 1988-05-20 1994-11-24 Liposome Co Inc Aktives mittel: lipid-komplex mit hohem verhältnis.
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
US4952405A (en) * 1988-10-20 1990-08-28 Liposome Technology, Inc. Method of treating M. avium infection
AU4525589A (en) * 1988-10-27 1990-05-14 Regents Of The University Of Minnesota Liposome immunoadjuvants containing il-2
EP0473645B1 (en) * 1989-05-25 1998-03-18 Technology Unlimited Incorporated Insect repellant
ZA911974B (en) * 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
EP0585514B1 (en) * 1992-01-09 1998-10-07 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin
US5344822A (en) * 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
US5674855A (en) * 1992-08-12 1997-10-07 The Rogosin Institute Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
US5958449A (en) * 1992-12-02 1999-09-28 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for bacterial infections
AU3244393A (en) * 1992-12-02 1994-06-22 Vestar, Inc. Antibiotic formulation and process
US5759571A (en) * 1993-05-11 1998-06-02 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for drug resistant infections
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
PT759774E (pt) * 1993-09-22 2002-11-29 Xoma Technology Ltd Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
EP0664117A1 (de) * 1994-01-25 1995-07-26 F. Hoffmann-La Roche Ag Liposomenlösungen
US20020028215A1 (en) 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
CA2253871C (en) 1996-05-08 2005-04-26 Biogen, Inc. Ret ligand (retl) for stimulating neural and renal growth
WO1998006435A2 (en) * 1996-08-14 1998-02-19 Vanderbilt University COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA)
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US20030130169A1 (en) * 2001-10-01 2003-07-10 The Board Of Trustees Of The University Of Illinois Methods of treating drug-resistant bacterial infections
CA2383259A1 (en) * 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
EP1476194A4 (en) * 2002-02-19 2005-05-18 Eden Research Plc COMPOSITIONS AND METHOD FOR PRESERVING FOODSTUFFS
CA2477979A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for treatment of intracellular infections
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
KR101301653B1 (ko) * 2002-10-29 2013-08-30 트랜세이브, 인코포레이티드 항감염제의 지속적인 방출
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US6846966B2 (en) * 2002-11-26 2005-01-25 Exxonmobil Chemical Patents Inc. Method and apparatus for treating oxygenate-containing feeds and their use in conversion of oxygenates to olefins
FR2852513A1 (fr) * 2003-03-17 2004-09-24 Groupe Lepine Combinaison d'antibiotiques gentamicine/clindamycine et ses applications aux ciments orthopediques curatifs
RU2385323C2 (ru) 2003-04-02 2010-03-27 ДЗЕ ГАВЕРМЕНТ ОФ ДЗЕ ЮНАЙТЕД СТЕЙТС ОФ АМЕРИКА Эз репрезентед бай ДЗЕ СЕКРЕТЭРИ, ДЕПАРТМЕНТ ОФ ХЕЛТ ЭНД ХЬЮМЭН СЕРВИСИЗ Холестеринсодержащие соединения и их применение в качестве иммуногенов против borrelia burgdorferi
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
CA2561577A1 (en) 2004-03-30 2005-10-13 Nsgene A/S Therapeutic use of a growth factor, nsg33
US20090136552A1 (en) * 2004-07-30 2009-05-28 Mette Gronborg Growth factors nsg28, nsg30, and nsg32
EP1796689A4 (en) * 2004-09-20 2009-01-14 British Columbia Cancer Agency GEMCITABINE FREE OR ENCAPSULATED IN LIPOSOMES ONLY OR IN ASSOCIATION WITH FREE IDARUBICIN OR ENCAPSULATED IN LIPOSOMES
US20110020434A1 (en) * 2005-09-02 2011-01-27 O'halloran Thomas V Nanoparticle arsenic-platinum compositions
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
CA2838111C (en) 2005-12-08 2016-01-19 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US8470762B2 (en) * 2007-05-31 2013-06-25 Colgate-Palmolive Company Fabric softening compositions comprising polymeric materials
US20110218140A1 (en) * 2008-02-25 2011-09-08 Gonsalves Kenneth E Biodegradable therapeutic nanoparticles containing an antimicrobial agent
BRPI0908565A2 (pt) 2008-03-06 2017-05-23 Anacor Pharmaceuticals Inc composto, formulação farmacêutica, métodos para reduzir a liberação de uma citocina ou de uma quimiocina, para tratar uma condição em um animal e para inibir uma fosfodiesterase
CA2767646C (en) 2009-07-10 2019-01-29 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
WO2011075688A1 (en) 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
JP2013532144A (ja) 2010-06-14 2013-08-15 ハー・ルンドベック・アクチエゼルスカベット ＳｏｒＬＡとＧＤＮＦファミリーリガンド受容体の間の相互作用の調節
US9212201B2 (en) * 2010-07-23 2015-12-15 Acea Biotech, Inc. Antifungal and antiparasitic polyene macrolides
AU2011307488B2 (en) 2010-10-01 2015-08-20 Hoba Therapeutics Aps Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
KR102277921B1 (ko) 2012-05-21 2021-07-14 인스메드 인코포레이티드 폐 감염을 치료하기 위한 시스템
EP3581186A1 (en) 2012-11-29 2019-12-18 Insmed Incorporated Stabilized vancomycin formulations
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
US10791740B2 (en) 2014-06-06 2020-10-06 The Curators Of The University Of Missouri Enhancement of antibiotic efficacy
US20170266106A1 (en) 2014-12-01 2017-09-21 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
KR20180069782A (ko) 2015-08-03 2018-06-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 하전 이온 채널 블록커 및 이용 방법
KR20190058477A (ko) 2016-08-17 2019-05-29 솔스티스 바이올로직스, 리미티드 폴리뉴클레오티드 구축물
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP3937945A4 (en) 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2022527438A (ja) 2019-03-11 2022-06-02 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
JP2022527731A (ja) 2019-03-11 2022-06-06 ノシオン セラピューティクス，インコーポレイテッド エステル置換イオンチャンネル遮断薬および使用方法
BR112022008575A2 (pt) 2019-11-06 2022-08-09 Nocion Therapeutics Inc Bloqueadores de canal iônico carregado e métodos para uso
JP7513713B2 (ja) 2019-11-06 2024-07-09 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
CN115279731A (zh) 2020-03-11 2022-11-01 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
EP4333872A1 (en) 2021-05-06 2024-03-13 Hoba Therapeutics ApS Prevention and treatment of chemotherapy-induced neuropathic pain
WO2023104960A1 (en) 2021-12-10 2023-06-15 Hoba Therapeutics Aps Treatment of nociceptive pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4328222A (en) * 1978-11-21 1982-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions for parenteral or local administration
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase

Also Published As

Publication number Publication date
EP0153364A1 (en) 1985-09-04
ES8603264A1 (es) 1985-12-16
AU3219484A (en) 1985-03-04
EP0153364A4 (en) 1987-03-03
SG18592G (en) 1992-04-16
CA1237671A (en) 1988-06-07
IT1179029B (it) 1987-09-16
WO1985000515A1 (en) 1985-02-14
IT8467767A0 (it) 1984-08-01
PT79012A (en) 1984-09-01
DE3483322D1 (de) 1990-10-31
IL72545A (en) 1987-11-30
US5000958A (en) 1991-03-19
ES542147A0 (es) 1985-12-16
EP0153364B1 (en) 1990-09-26

Similar Documents

Publication Publication Date Title
IT8467767A1 (it) Preparati farmaceutici ad attività antimicrobica e procedimento per la loro preparazione.
IT1158039B (it) 2-/4-/(4,4-dialchil-2,6-piperidindion-1-il)-butil/1-piperazinil/pirimidine ad attivita' ansiolitica selettiva, procedimento per la loro preparazione e preparati farmaceutici che le contengono
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
BR8802557A (pt) Agente fisiologicamente ativo para uso agricola
IT8421241A0 (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
IT1224701B (it) Preparati farmaceutici antimicrobici per applicazione topica e procedimento per la loro produzione
ZA845682B (en) Benzamidine derivatives having an antimicrobial activity process for their preparation and use as disinfectant drugs or preservatives
IT8320468A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8322045A0 (it) Per la loro preparazione e oligosaccaridi eterogenei relative composizioni complessabili ed alfa -idosani ad farmaceutiche. attivita' terapeutica, procedimento
IT1167746B (it) Nitroimidazoli ad attivita' tricomonacida, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1212753B (it) Composti polienici,procedimento per la loro preparazione e preparati farmaceutici che li contengono
IT1211944B (it) Derivati azolici,procedimento per la loro produzione,preparati farmaceutici che li contengono,e loro impiego
IT8321607A1 (it) Preparati farmaceutici topici ad attività antisettica ed antiinfiammatoria spinta, e procedimento per la loro preparazione
IT8567216A0 (it) Composti pteridinici relativi procedimenti di preparazione e preparati farmaceutici che li contengono
IT1196147B (it) Preparati farmaceutici con azione antitumorale
IT8520653A0 (it) Composti ad attivita'antibatterica, loro preparazione e composizioni farmaceutiche relative.
IT1168615B (it) Composti di amminoimidazolile, procedimenti per la loro produzione e preparati farmaceutici che contengono questi composti
IT8519065A0 (it) Composti con attivita' antitossica ed antianemica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8520150A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8222494A0 (it) Derivati ad attivita'espettorante, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8321358A0 (it) Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8519975A0 (it) Composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8321044A0 (it) Per la loro preparazione e relative composti idrossiminici e composizioni farmaceutiche. alcossiminici ad attivita'calcio-antagonista, procedimento
IT8320672A0 (it) Nuovi composti ad attivita'antineoplastica, procedimento per la loro preparazione e relative composizioni farmaceutiche.